Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Assets Average (2021 - 2023)

Cullinan Therapeutics (CGEM) has 3 years of Assets Average data on record, last reported at $508.3 million in Q3 2023.

  • For Q3 2023, Assets Average fell 20.85% year-over-year to $508.3 million; the TTM value through Sep 2023 reached $508.3 million, down 20.85%, while the annual FY2022 figure was $499.2 million, 53.14% up from the prior year.
  • Assets Average reached $508.3 million in Q3 2023 per CGEM's latest filing, down from $518.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $642.2 million in Q3 2022 and bottomed at $347.2 million in Q1 2021.
  • Average Assets Average over 3 years is $500.9 million, with a median of $508.3 million recorded in 2023.
  • Peak YoY movement for Assets Average: surged 39.96% in 2022, then decreased 20.85% in 2023.
  • A 3-year view of Assets Average shows it stood at $445.3 million in 2021, then soared by 32.31% to $589.2 million in 2022, then dropped by 13.72% to $508.3 million in 2023.
  • Per Business Quant database, its latest 3 readings for Assets Average were $508.3 million in Q3 2023, $518.5 million in Q2 2023, and $538.1 million in Q1 2023.